| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Cyabra, Inc.
13G
CYAB · 23249H105
|
8.4% |
9/22/2026
Event 9/8/2026
|
||||
|
GT Biopharma, Inc.
13G
GTBP · 36254L407
|
10.0% |
9/15/2026
Event 9/15/2026
|
||||
|
Nuvve Holding Corp.
13G
NVVE · 67079Y506
|
10.0% |
7/22/2026
Event 7/16/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.